You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 9, March 7, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Lab Reports
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Drug Therapy, Other
 •Alert me on articles by topic

Pneumonic Plague

Tracy Hampton, PhD

JAMA. 2007;297:941.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Blocking a key molecule of Yersinia pestis, the bacterium that causes plague, may help slow the progression of the pneumonic form of the disease and allow antibiotics time to work, according to new research conducted at Washington University School of Medicine, in St Louis, Mo (Lathem WW et al. Science. 2007;315:509-513). Y pestis is best known for causing the Black Death in the Middle Ages, when it killed a third or more of the European population.

Until now, the mechanisms by which Y pestis overwhelms the lungs have remained unclear. But this latest research suggests that a virulence factor called plasminogen activator (Pla) allows the bacterium to replicate rapidly in the airways and cause pneumonia. Mice injected with Y pestis died within 3.5 days, but of those injected with a strain that lacked Pla, only half had developed terminal plague after 7 days.

The investigators . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.